MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr |
What is the latest Total Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹294 Cr |
| Mar2024 | ₹292 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹225 Cr |
| Mar2021 | ₹194 Cr |
How is Total Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹294 Cr | 0.78 | |
| Mar2024 | ₹292 Cr | 5.57 | |
| Mar2023 | ₹277 Cr | 22.84 | |
| Mar2022 | ₹225 Cr | 16.08 | |
| Mar2021 | ₹194 Cr | - | |
Compare Total Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹358.4 Cr | 14.8% | 5.7% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 14.8% |
5.7% |
-21.7% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses